nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC22A5—ulcerative colitis	0.479	1	CbGaD
Methamphetamine—MAOB—Nicotine—ulcerative colitis	0.126	0.3	CbGbCtD
Methamphetamine—SLC22A3—Nicotine—ulcerative colitis	0.0992	0.236	CbGbCtD
Methamphetamine—MAOA—Nicotine—ulcerative colitis	0.0992	0.236	CbGbCtD
Methamphetamine—SLC22A5—Nicotine—ulcerative colitis	0.0616	0.147	CbGbCtD
Methamphetamine—CYP2D6—Nicotine—ulcerative colitis	0.0147	0.0351	CbGbCtD
Methamphetamine—CYP2D6—Cholecalciferol—ulcerative colitis	0.0132	0.0315	CbGbCtD
Methamphetamine—CYP2D6—Dexamethasone—ulcerative colitis	0.00572	0.0136	CbGbCtD
Methamphetamine—Pseudoephedrine—IL2—ulcerative colitis	0.000863	0.275	CrCbGaD
Methamphetamine—Psychotic disorder—Budesonide—ulcerative colitis	0.000439	0.0241	CcSEcCtD
Methamphetamine—Tremor—Nicotine—ulcerative colitis	0.000368	0.0202	CcSEcCtD
Methamphetamine—Agitation—Nicotine—ulcerative colitis	0.000361	0.0198	CcSEcCtD
Methamphetamine—Amphetamine—SLC22A5—ulcerative colitis	0.000361	0.115	CrCbGaD
Methamphetamine—Palpitations—Nicotine—ulcerative colitis	0.000347	0.0191	CcSEcCtD
Methamphetamine—Ephedrine—ADRB2—ulcerative colitis	0.000341	0.109	CrCbGaD
Methamphetamine—Euphoric mood—Prednisolone—ulcerative colitis	0.000315	0.0173	CcSEcCtD
Methamphetamine—Tachycardia—Nicotine—ulcerative colitis	0.000313	0.0172	CcSEcCtD
Methamphetamine—Euphoric mood—Hydrocortisone—ulcerative colitis	0.000308	0.0169	CcSEcCtD
Methamphetamine—Phenylpropanolamine—ADRB2—ulcerative colitis	0.000306	0.0974	CrCbGaD
Methamphetamine—Pseudoephedrine—TNF—ulcerative colitis	0.000291	0.0928	CrCbGaD
Methamphetamine—Insomnia—Nicotine—ulcerative colitis	0.00029	0.0159	CcSEcCtD
Methamphetamine—Euphoric mood—Triamcinolone—ulcerative colitis	0.00029	0.0159	CcSEcCtD
Methamphetamine—Euphoric mood—Methylprednisolone—ulcerative colitis	0.000289	0.0159	CcSEcCtD
Methamphetamine—Nateglinide—PPARG—ulcerative colitis	0.000286	0.0911	CrCbGaD
Methamphetamine—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000286	0.0157	CcSEcCtD
Methamphetamine—Dyspepsia—Nicotine—ulcerative colitis	0.000282	0.0155	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000277	0.0152	CcSEcCtD
Methamphetamine—Constipation—Nicotine—ulcerative colitis	0.000274	0.015	CcSEcCtD
Methamphetamine—Euphoric mood—Dexamethasone—ulcerative colitis	0.000263	0.0144	CcSEcCtD
Methamphetamine—Euphoric mood—Betamethasone—ulcerative colitis	0.000263	0.0144	CcSEcCtD
Methamphetamine—Pseudoephedrine—ADRB2—ulcerative colitis	0.000258	0.0823	CrCbGaD
Methamphetamine—Urticaria—Nicotine—ulcerative colitis	0.000255	0.014	CcSEcCtD
Methamphetamine—Psychotic disorder—Hydrocortisone—ulcerative colitis	0.000254	0.0139	CcSEcCtD
Methamphetamine—Tremor—Budesonide—ulcerative colitis	0.000254	0.0139	CcSEcCtD
Methamphetamine—Agitation—Budesonide—ulcerative colitis	0.000249	0.0136	CcSEcCtD
Methamphetamine—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000244	0.0134	CcSEcCtD
Methamphetamine—Palpitations—Budesonide—ulcerative colitis	0.000239	0.0131	CcSEcCtD
Methamphetamine—Psychotic disorder—Methylprednisolone—ulcerative colitis	0.000239	0.0131	CcSEcCtD
Methamphetamine—Hypersensitivity—Nicotine—ulcerative colitis	0.000236	0.013	CcSEcCtD
Methamphetamine—Euphoric mood—Prednisone—ulcerative colitis	0.000229	0.0126	CcSEcCtD
Methamphetamine—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000227	0.0124	CcSEcCtD
Methamphetamine—Diarrhoea—Nicotine—ulcerative colitis	0.00022	0.012	CcSEcCtD
Methamphetamine—Psychotic disorder—Dexamethasone—ulcerative colitis	0.000217	0.0119	CcSEcCtD
Methamphetamine—Psychotic disorder—Betamethasone—ulcerative colitis	0.000217	0.0119	CcSEcCtD
Methamphetamine—Tachycardia—Budesonide—ulcerative colitis	0.000216	0.0118	CcSEcCtD
Methamphetamine—Dizziness—Nicotine—ulcerative colitis	0.000212	0.0116	CcSEcCtD
Methamphetamine—Nateglinide—PTGS1—ulcerative colitis	0.000211	0.0673	CrCbGaD
Methamphetamine—Tremor—Mesalazine—ulcerative colitis	0.000206	0.0113	CcSEcCtD
Methamphetamine—Headache—Nicotine—ulcerative colitis	0.000201	0.011	CcSEcCtD
Methamphetamine—Insomnia—Budesonide—ulcerative colitis	0.0002	0.011	CcSEcCtD
Methamphetamine—Palpitations—Mesalazine—ulcerative colitis	0.000195	0.0107	CcSEcCtD
Methamphetamine—Dyspepsia—Budesonide—ulcerative colitis	0.000194	0.0107	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000191	0.0105	CcSEcCtD
Methamphetamine—Constipation—Budesonide—ulcerative colitis	0.000189	0.0104	CcSEcCtD
Methamphetamine—Psychotic disorder—Prednisone—ulcerative colitis	0.000189	0.0104	CcSEcCtD
Methamphetamine—Urticaria—Budesonide—ulcerative colitis	0.000176	0.00963	CcSEcCtD
Methamphetamine—Tachycardia—Mesalazine—ulcerative colitis	0.000175	0.00962	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00017	0.00934	CcSEcCtD
Methamphetamine—Hypersensitivity—Budesonide—ulcerative colitis	0.000163	0.00893	CcSEcCtD
Methamphetamine—Insomnia—Mesalazine—ulcerative colitis	0.000163	0.00891	CcSEcCtD
Methamphetamine—Dyspepsia—Mesalazine—ulcerative colitis	0.000158	0.00867	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000155	0.00851	CcSEcCtD
Methamphetamine—Erectile dysfunction—Prednisone—ulcerative colitis	0.000154	0.00844	CcSEcCtD
Methamphetamine—Constipation—Mesalazine—ulcerative colitis	0.000154	0.00843	CcSEcCtD
Methamphetamine—Diarrhoea—Budesonide—ulcerative colitis	0.000151	0.00829	CcSEcCtD
Methamphetamine—Dizziness—Budesonide—ulcerative colitis	0.000146	0.00801	CcSEcCtD
Methamphetamine—Hypersensitivity—Azathioprine—ulcerative colitis	0.000145	0.00797	CcSEcCtD
Methamphetamine—Urticaria—Mesalazine—ulcerative colitis	0.000143	0.00783	CcSEcCtD
Methamphetamine—Headache—Budesonide—ulcerative colitis	0.000138	0.00759	CcSEcCtD
Methamphetamine—Diarrhoea—Azathioprine—ulcerative colitis	0.000135	0.0074	CcSEcCtD
Methamphetamine—Hypersensitivity—Mesalazine—ulcerative colitis	0.000132	0.00726	CcSEcCtD
Methamphetamine—Dizziness—Azathioprine—ulcerative colitis	0.00013	0.00715	CcSEcCtD
Methamphetamine—Tachycardia—Prednisolone—ulcerative colitis	0.000128	0.007	CcSEcCtD
Methamphetamine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000125	0.00684	CcSEcCtD
Methamphetamine—Headache—Azathioprine—ulcerative colitis	0.000124	0.00678	CcSEcCtD
Methamphetamine—Diarrhoea—Mesalazine—ulcerative colitis	0.000123	0.00674	CcSEcCtD
Methamphetamine—Dizziness—Mesalazine—ulcerative colitis	0.000119	0.00652	CcSEcCtD
Methamphetamine—Insomnia—Prednisolone—ulcerative colitis	0.000118	0.00649	CcSEcCtD
Methamphetamine—Tachycardia—Triamcinolone—ulcerative colitis	0.000117	0.00644	CcSEcCtD
Methamphetamine—Tachycardia—Methylprednisolone—ulcerative colitis	0.000117	0.00643	CcSEcCtD
Methamphetamine—Insomnia—Hydrocortisone—ulcerative colitis	0.000116	0.00634	CcSEcCtD
Methamphetamine—Selegiline—ABCB1—ulcerative colitis	0.000115	0.0366	CrCbGaD
Methamphetamine—Headache—Mesalazine—ulcerative colitis	0.000113	0.00617	CcSEcCtD
Methamphetamine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000112	0.00617	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00011	0.00605	CcSEcCtD
Methamphetamine—Insomnia—Triamcinolone—ulcerative colitis	0.000109	0.00597	CcSEcCtD
Methamphetamine—Insomnia—Methylprednisolone—ulcerative colitis	0.000109	0.00595	CcSEcCtD
Methamphetamine—Nateglinide—ALB—ulcerative colitis	0.000108	0.0343	CrCbGaD
Methamphetamine—Agitation—Prednisone—ulcerative colitis	0.000107	0.00587	CcSEcCtD
Methamphetamine—Tachycardia—Dexamethasone—ulcerative colitis	0.000107	0.00584	CcSEcCtD
Methamphetamine—Tachycardia—Betamethasone—ulcerative colitis	0.000107	0.00584	CcSEcCtD
Methamphetamine—Dyspepsia—Triamcinolone—ulcerative colitis	0.000106	0.00581	CcSEcCtD
Methamphetamine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000106	0.0058	CcSEcCtD
Methamphetamine—Urticaria—Prednisolone—ulcerative colitis	0.000104	0.0057	CcSEcCtD
Methamphetamine—Urticaria—Hydrocortisone—ulcerative colitis	0.000102	0.00557	CcSEcCtD
Methamphetamine—Insomnia—Dexamethasone—ulcerative colitis	9.87e-05	0.00542	CcSEcCtD
Methamphetamine—Insomnia—Betamethasone—ulcerative colitis	9.87e-05	0.00542	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisolone—ulcerative colitis	9.64e-05	0.00529	CcSEcCtD
Methamphetamine—Dyspepsia—Betamethasone—ulcerative colitis	9.61e-05	0.00527	CcSEcCtD
Methamphetamine—Dyspepsia—Dexamethasone—ulcerative colitis	9.61e-05	0.00527	CcSEcCtD
Methamphetamine—Urticaria—Triamcinolone—ulcerative colitis	9.56e-05	0.00524	CcSEcCtD
Methamphetamine—Urticaria—Methylprednisolone—ulcerative colitis	9.54e-05	0.00523	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.42e-05	0.00517	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.42e-05	0.00517	CcSEcCtD
Methamphetamine—Hypersensitivity—Hydrocortisone—ulcerative colitis	9.41e-05	0.00516	CcSEcCtD
Methamphetamine—Tachycardia—Prednisone—ulcerative colitis	9.28e-05	0.00509	CcSEcCtD
Methamphetamine—Hypersensitivity—Triamcinolone—ulcerative colitis	8.86e-05	0.00486	CcSEcCtD
Methamphetamine—Hypersensitivity—Methylprednisolone—ulcerative colitis	8.84e-05	0.00485	CcSEcCtD
Methamphetamine—Diarrhoea—Hydrocortisone—ulcerative colitis	8.74e-05	0.00479	CcSEcCtD
Methamphetamine—Urticaria—Betamethasone—ulcerative colitis	8.67e-05	0.00476	CcSEcCtD
Methamphetamine—Urticaria—Dexamethasone—ulcerative colitis	8.67e-05	0.00476	CcSEcCtD
Methamphetamine—Dizziness—Prednisolone—ulcerative colitis	8.65e-05	0.00474	CcSEcCtD
Methamphetamine—Insomnia—Prednisone—ulcerative colitis	8.6e-05	0.00472	CcSEcCtD
Methamphetamine—Dizziness—Hydrocortisone—ulcerative colitis	8.45e-05	0.00463	CcSEcCtD
Methamphetamine—Dyspepsia—Prednisone—ulcerative colitis	8.37e-05	0.00459	CcSEcCtD
Methamphetamine—Diarrhoea—Methylprednisolone—ulcerative colitis	8.21e-05	0.0045	CcSEcCtD
Methamphetamine—Headache—Prednisolone—ulcerative colitis	8.2e-05	0.0045	CcSEcCtD
Methamphetamine—Constipation—Prednisone—ulcerative colitis	8.13e-05	0.00446	CcSEcCtD
Methamphetamine—Headache—Hydrocortisone—ulcerative colitis	8e-05	0.00439	CcSEcCtD
Methamphetamine—Dizziness—Triamcinolone—ulcerative colitis	7.96e-05	0.00436	CcSEcCtD
Methamphetamine—Dizziness—Methylprednisolone—ulcerative colitis	7.94e-05	0.00435	CcSEcCtD
Methamphetamine—Urticaria—Prednisone—ulcerative colitis	7.55e-05	0.00414	CcSEcCtD
Methamphetamine—Headache—Triamcinolone—ulcerative colitis	7.54e-05	0.00413	CcSEcCtD
Methamphetamine—Headache—Methylprednisolone—ulcerative colitis	7.52e-05	0.00412	CcSEcCtD
Methamphetamine—Diarrhoea—Dexamethasone—ulcerative colitis	7.47e-05	0.0041	CcSEcCtD
Methamphetamine—Diarrhoea—Betamethasone—ulcerative colitis	7.47e-05	0.0041	CcSEcCtD
Methamphetamine—Dizziness—Dexamethasone—ulcerative colitis	7.22e-05	0.00396	CcSEcCtD
Methamphetamine—Dizziness—Betamethasone—ulcerative colitis	7.22e-05	0.00396	CcSEcCtD
Methamphetamine—Hypersensitivity—Prednisone—ulcerative colitis	7e-05	0.00384	CcSEcCtD
Methamphetamine—Headache—Dexamethasone—ulcerative colitis	6.84e-05	0.00375	CcSEcCtD
Methamphetamine—Headache—Betamethasone—ulcerative colitis	6.84e-05	0.00375	CcSEcCtD
Methamphetamine—Diarrhoea—Prednisone—ulcerative colitis	6.5e-05	0.00357	CcSEcCtD
Methamphetamine—Dizziness—Prednisone—ulcerative colitis	6.29e-05	0.00345	CcSEcCtD
Methamphetamine—Headache—Prednisone—ulcerative colitis	5.96e-05	0.00327	CcSEcCtD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCR2—ulcerative colitis	3.21e-05	0.000403	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—CXCL8—ulcerative colitis	3.21e-05	0.000403	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—GNA12—ulcerative colitis	3.16e-05	0.000397	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—TNF—ulcerative colitis	3.12e-05	0.000391	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCR1—ulcerative colitis	3.11e-05	0.000391	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—GNA12—ulcerative colitis	3.07e-05	0.000386	CbGpPWpGaD
Methamphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—ulcerative colitis	3.07e-05	0.000385	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—IL2—ulcerative colitis	3.07e-05	0.000385	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	3.05e-05	0.000383	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCL20—ulcerative colitis	3.05e-05	0.000383	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CHP1—ulcerative colitis	3.05e-05	0.000383	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS1—ulcerative colitis	3.04e-05	0.000381	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CCR6—ulcerative colitis	3.02e-05	0.000379	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCR2—ulcerative colitis	3e-05	0.000376	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.99e-05	0.000375	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCR2—ulcerative colitis	2.91e-05	0.000366	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GNA12—ulcerative colitis	2.87e-05	0.00036	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	2.85e-05	0.000358	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—CXCL8—ulcerative colitis	2.84e-05	0.000357	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—CALM3—ulcerative colitis	2.83e-05	0.000355	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCR1—ulcerative colitis	2.82e-05	0.000355	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CCR6—ulcerative colitis	2.82e-05	0.000354	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.79e-05	0.00035	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.78e-05	0.000349	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCR6—ulcerative colitis	2.74e-05	0.000344	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—TP53—ulcerative colitis	2.74e-05	0.000344	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CALM3—ulcerative colitis	2.73e-05	0.000343	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCL20—ulcerative colitis	2.73e-05	0.000343	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCR2—ulcerative colitis	2.72e-05	0.000342	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—ADRB2—ulcerative colitis	2.7e-05	0.000339	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SEL1L—ulcerative colitis	2.67e-05	0.000335	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	2.67e-05	0.000335	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	2.66e-05	0.000334	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PTGER4—ulcerative colitis	2.66e-05	0.000333	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—CXCL8—ulcerative colitis	2.65e-05	0.000333	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.65e-05	0.000332	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—DLD—ulcerative colitis	2.63e-05	0.000331	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS1—ulcerative colitis	2.57e-05	0.000323	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GNA12—ulcerative colitis	2.57e-05	0.000322	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCR6—ulcerative colitis	2.56e-05	0.000321	CbGpPWpGaD
Methamphetamine—MAOA—SIDS Susceptibility Pathways—IL6—ulcerative colitis	2.51e-05	0.000316	CbGpPWpGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—IL6—ulcerative colitis	2.5e-05	0.000315	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SEL1L—ulcerative colitis	2.49e-05	0.000313	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PTGER4—ulcerative colitis	2.48e-05	0.000311	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	2.48e-05	0.000311	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL20—ulcerative colitis	2.48e-05	0.000311	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.47e-05	0.00031	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCR2—ulcerative colitis	2.43e-05	0.000306	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—GHRL—ulcerative colitis	2.43e-05	0.000305	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PTGER4—ulcerative colitis	2.41e-05	0.000303	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.4e-05	0.000302	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.39e-05	0.000301	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—MMP1—ulcerative colitis	2.39e-05	0.0003	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GNA12—ulcerative colitis	2.33e-05	0.000293	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CALM3—ulcerative colitis	2.31e-05	0.00029	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCR6—ulcerative colitis	2.29e-05	0.000287	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—GHRL—ulcerative colitis	2.27e-05	0.000285	CbGpPWpGaD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.26e-05	0.000284	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PTGER4—ulcerative colitis	2.25e-05	0.000283	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—MMP1—ulcerative colitis	2.23e-05	0.000281	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.22e-05	0.000279	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCR2—ulcerative colitis	2.21e-05	0.000278	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—GHRL—ulcerative colitis	2.21e-05	0.000277	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCR1—ulcerative colitis	2.2e-05	0.000276	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	2.16e-05	0.000272	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—CXCL8—ulcerative colitis	2.15e-05	0.000271	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CALM3—ulcerative colitis	2.14e-05	0.000268	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ABCB1—ulcerative colitis	2.13e-05	0.000267	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.11e-05	0.000265	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCR6—ulcerative colitis	2.08e-05	0.000261	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.08e-05	0.000261	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—JAK2—ulcerative colitis	2.08e-05	0.000261	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GHRL—ulcerative colitis	2.06e-05	0.000259	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCR1—ulcerative colitis	2.05e-05	0.000258	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SEL1L—ulcerative colitis	2.03e-05	0.000254	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PTGER4—ulcerative colitis	2.01e-05	0.000253	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—ADRB2—ulcerative colitis	2.01e-05	0.000253	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—RELA—ulcerative colitis	2.01e-05	0.000252	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CALM3—ulcerative colitis	2e-05	0.000251	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.99e-05	0.00025	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ADCY5—ulcerative colitis	1.98e-05	0.000249	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL20—ulcerative colitis	1.93e-05	0.000242	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS1—ulcerative colitis	1.91e-05	0.000239	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CXCL8—ulcerative colitis	1.89e-05	0.000238	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—ADRB2—ulcerative colitis	1.88e-05	0.000236	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.87e-05	0.000235	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GHRL—ulcerative colitis	1.84e-05	0.000232	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PTGER4—ulcerative colitis	1.83e-05	0.00023	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—ADRB2—ulcerative colitis	1.83e-05	0.000229	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GNA12—ulcerative colitis	1.82e-05	0.000228	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—MMP1—ulcerative colitis	1.81e-05	0.000228	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—ALB—ulcerative colitis	1.81e-05	0.000228	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL2—ulcerative colitis	1.81e-05	0.000227	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL20—ulcerative colitis	1.8e-05	0.000226	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—IL6—ulcerative colitis	1.8e-05	0.000226	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ABCB1—ulcerative colitis	1.8e-05	0.000226	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCR2—ulcerative colitis	1.72e-05	0.000216	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CXCL8—ulcerative colitis	1.72e-05	0.000216	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—DLD—ulcerative colitis	1.72e-05	0.000215	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CALM3—ulcerative colitis	1.72e-05	0.000215	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—MMP9—ulcerative colitis	1.71e-05	0.000215	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.71e-05	0.000215	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—ADCY5—ulcerative colitis	1.71e-05	0.000214	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—ADRB2—ulcerative colitis	1.71e-05	0.000214	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GNA12—ulcerative colitis	1.7e-05	0.000213	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NFKB1—ulcerative colitis	1.7e-05	0.000213	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—ALB—ulcerative colitis	1.69e-05	0.000213	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.69e-05	0.000212	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—JAK2—ulcerative colitis	1.68e-05	0.000212	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ADCY5—ulcerative colitis	1.68e-05	0.000211	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GHRL—ulcerative colitis	1.67e-05	0.00021	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCR1—ulcerative colitis	1.67e-05	0.00021	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.66e-05	0.000208	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CALM3—ulcerative colitis	1.62e-05	0.000204	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCR6—ulcerative colitis	1.62e-05	0.000203	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCR2—ulcerative colitis	1.61e-05	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CXCL8—ulcerative colitis	1.61e-05	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—ADCY5—ulcerative colitis	1.6e-05	0.0002	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—JAK2—ulcerative colitis	1.57e-05	0.000198	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS1—ulcerative colitis	1.57e-05	0.000197	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—ADCY5—ulcerative colitis	1.55e-05	0.000195	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAML2—ulcerative colitis	1.53e-05	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	1.53e-05	0.000192	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—STAT3—ulcerative colitis	1.52e-05	0.000191	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR6—ulcerative colitis	1.51e-05	0.00019	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PPARG—ulcerative colitis	1.48e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IL2—ulcerative colitis	1.47e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	1.46e-05	0.000184	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—ADCY5—ulcerative colitis	1.45e-05	0.000182	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAML2—ulcerative colitis	1.43e-05	0.00018	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTGER4—ulcerative colitis	1.42e-05	0.000179	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TGFB1—ulcerative colitis	1.41e-05	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CALM3—ulcerative colitis	1.41e-05	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	1.39e-05	0.000174	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	1.38e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—ALB—ulcerative colitis	1.38e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IL2—ulcerative colitis	1.37e-05	0.000172	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ABCB1—ulcerative colitis	1.33e-05	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTGER4—ulcerative colitis	1.33e-05	0.000167	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ALB—ulcerative colitis	1.33e-05	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	1.31e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	1.3e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GHRL—ulcerative colitis	1.3e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.3e-05	0.000163	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—JAK2—ulcerative colitis	1.28e-05	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS1—ulcerative colitis	1.27e-05	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CALM3—ulcerative colitis	1.26e-05	0.000159	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PPARG—ulcerative colitis	1.25e-05	0.000157	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ADCY5—ulcerative colitis	1.24e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RIPK2—ulcerative colitis	1.24e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	1.23e-05	0.000154	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GHRL—ulcerative colitis	1.22e-05	0.000153	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CALM3—ulcerative colitis	1.18e-05	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	1.18e-05	0.000148	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	1.16e-05	0.000146	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—ulcerative colitis	1.16e-05	0.000146	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—ulcerative colitis	1.16e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RIPK2—ulcerative colitis	1.16e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TGFB1—ulcerative colitis	1.15e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CALM3—ulcerative colitis	1.15e-05	0.000144	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—ulcerative colitis	1.13e-05	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2—ulcerative colitis	1.12e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ABCB1—ulcerative colitis	1.1e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	1.08e-05	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADRB2—ulcerative colitis	1.08e-05	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TGFB1—ulcerative colitis	1.07e-05	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—JAK2—ulcerative colitis	1.06e-05	0.000134	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—ulcerative colitis	1.06e-05	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ADCY5—ulcerative colitis	1.02e-05	0.000129	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADRB2—ulcerative colitis	1.01e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—JAK2—ulcerative colitis	9.95e-06	0.000125	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	9.89e-06	0.000124	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—ulcerative colitis	9.84e-06	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCL8—ulcerative colitis	9.72e-06	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—JAK2—ulcerative colitis	9.67e-06	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	9.58e-06	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	9.44e-06	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—ulcerative colitis	9.44e-06	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2—ulcerative colitis	9.29e-06	0.000117	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPARG—ulcerative colitis	9.28e-06	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADCY5—ulcerative colitis	9.16e-06	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCL8—ulcerative colitis	9.08e-06	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—JAK2—ulcerative colitis	9.03e-06	0.000113	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ABCB1—ulcerative colitis	8.91e-06	0.000112	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	8.83e-06	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—ulcerative colitis	8.82e-06	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	8.7e-06	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2—ulcerative colitis	8.68e-06	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADCY5—ulcerative colitis	8.56e-06	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	8.43e-06	0.000106	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—ulcerative colitis	8.34e-06	0.000105	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ADCY5—ulcerative colitis	8.31e-06	0.000104	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	8.29e-06	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCL8—ulcerative colitis	8.24e-06	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	8.19e-06	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	8.08e-06	0.000101	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2—ulcerative colitis	7.88e-06	9.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—ulcerative colitis	7.63e-06	9.59e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CALM3—ulcerative colitis	7.47e-06	9.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	7.37e-06	9.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	7.34e-06	9.21e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—ulcerative colitis	7.3e-06	9.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—ulcerative colitis	7.16e-06	8.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	7.05e-06	8.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	6.95e-06	8.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—ulcerative colitis	6.86e-06	8.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	6.7e-06	8.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	6.4e-06	8.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—ulcerative colitis	6.2e-06	7.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—ulcerative colitis	6.01e-06	7.54e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	5.81e-06	7.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	5.71e-06	7.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—ulcerative colitis	5.58e-06	7e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	5.53e-06	6.95e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	5.42e-06	6.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	5.34e-06	6.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	5.21e-06	6.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	5.17e-06	6.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	4.98e-06	6.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	4.96e-06	6.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—ulcerative colitis	4.88e-06	6.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	4.87e-06	6.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	4.72e-06	5.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	4.67e-06	5.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	4.65e-06	5.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	4.63e-06	5.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	4.4e-06	5.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	4.36e-06	5.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	4.33e-06	5.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	4.2e-06	5.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	4.19e-06	5.26e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—ulcerative colitis	4.04e-06	5.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	3.96e-06	4.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	3.92e-06	4.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	3.89e-06	4.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	3.78e-06	4.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	3.76e-06	4.72e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—ulcerative colitis	3.63e-06	4.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	3.63e-06	4.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	3.58e-06	4.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	3.54e-06	4.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	3.2e-06	4.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	3.18e-06	3.99e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	3.18e-06	3.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	2.99e-06	3.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	2.95e-06	3.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	2.93e-06	3.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	2.74e-06	3.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	2.43e-06	3.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	2.22e-06	2.79e-05	CbGpPWpGaD
